Skip to main content
Dryad

Supplementary data from: Green synthesis, characterization, antileishmanial activity, and in silico investigations of Hydrazone Schiff Bases

Data files

Oct 06, 2024 version files 10.40 MB

Abstract

Hydrazone Schiff bases have significant biological and chemotherapeutic potential. This study explores their synthesis using environmentally friendly methods. The process involves combining substituted aldehydes, ketones, and amines with a small amount of glacial acetic acid in a mortar, achieving high yields of the desired compounds. Seven new hydrazone Schiff bases were successfully synthesized and identified through physical properties and spectroscopic techniques (FT-IR, 1H NMR, and 13C NMR). The compounds were tested for their antileishmanial activity against Leishmania tropica promastigotes. While all but one compound showed activity, SSB28 exhibited the highest potency with an IC50 value of 4 ± 0.5 µg/mL, outperforming the reference drug Amphotericin-B. In-silico studies, including molecular docking and ADMET assays, confirmed the promising antileishmanial potential of SSB28.